Speaker: Florian Krammer, PhD, Professor of Microbiology, Icahn School of Medicine at Mount Sinai
Original broadcast: “From COVID to Clinic: The Evolution of the Mount Sinai Antibody Test” webinar on July 15, 2020
The Mount Sinai serologic test received FDA emergency use authorization (EUA) for its qualitative use and EUA from the New York State Department of Health (NYSDOH) for quantitative use, making Mount Sinai’s lab the first in the country to run an authorized, fully quantitative antibody test that can deliver a precise numeric measurement of the level of antibodies in a patient’s blood.
Learn more: [ Ссылка ]
